Systemic mastocytosis, in the context of a deleterious germline SDHC variant, treated with ripretinib

Detalles Bibliográficos
Autores principales: Saheb Kashaf, Sara, Godley, Lucy A., Chadha, Angad, Waldinger, Jason B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315773/
https://www.ncbi.nlm.nih.gov/pubmed/37405177
http://dx.doi.org/10.1016/j.jdcr.2023.04.007
_version_ 1785067570292850688
author Saheb Kashaf, Sara
Godley, Lucy A.
Chadha, Angad
Waldinger, Jason B.
author_facet Saheb Kashaf, Sara
Godley, Lucy A.
Chadha, Angad
Waldinger, Jason B.
author_sort Saheb Kashaf, Sara
collection PubMed
description
format Online
Article
Text
id pubmed-10315773
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-103157732023-07-04 Systemic mastocytosis, in the context of a deleterious germline SDHC variant, treated with ripretinib Saheb Kashaf, Sara Godley, Lucy A. Chadha, Angad Waldinger, Jason B. JAAD Case Rep Case Report Elsevier 2023-04-24 /pmc/articles/PMC10315773/ /pubmed/37405177 http://dx.doi.org/10.1016/j.jdcr.2023.04.007 Text en © 2023 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Saheb Kashaf, Sara
Godley, Lucy A.
Chadha, Angad
Waldinger, Jason B.
Systemic mastocytosis, in the context of a deleterious germline SDHC variant, treated with ripretinib
title Systemic mastocytosis, in the context of a deleterious germline SDHC variant, treated with ripretinib
title_full Systemic mastocytosis, in the context of a deleterious germline SDHC variant, treated with ripretinib
title_fullStr Systemic mastocytosis, in the context of a deleterious germline SDHC variant, treated with ripretinib
title_full_unstemmed Systemic mastocytosis, in the context of a deleterious germline SDHC variant, treated with ripretinib
title_short Systemic mastocytosis, in the context of a deleterious germline SDHC variant, treated with ripretinib
title_sort systemic mastocytosis, in the context of a deleterious germline sdhc variant, treated with ripretinib
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315773/
https://www.ncbi.nlm.nih.gov/pubmed/37405177
http://dx.doi.org/10.1016/j.jdcr.2023.04.007
work_keys_str_mv AT sahebkashafsara systemicmastocytosisinthecontextofadeleteriousgermlinesdhcvarianttreatedwithripretinib
AT godleylucya systemicmastocytosisinthecontextofadeleteriousgermlinesdhcvarianttreatedwithripretinib
AT chadhaangad systemicmastocytosisinthecontextofadeleteriousgermlinesdhcvarianttreatedwithripretinib
AT waldingerjasonb systemicmastocytosisinthecontextofadeleteriousgermlinesdhcvarianttreatedwithripretinib

Ejemplares similares